Presentation is loading. Please wait.

Presentation is loading. Please wait.

From: Intravitreal pharmacokinetic properties and systemic biodistribution characteristics of I-124 labeled bevacizumab, ranibizumab and aflibercept with.

Similar presentations


Presentation on theme: "From: Intravitreal pharmacokinetic properties and systemic biodistribution characteristics of I-124 labeled bevacizumab, ranibizumab and aflibercept with."— Presentation transcript:

1 From: Intravitreal pharmacokinetic properties and systemic biodistribution characteristics of I-124 labeled bevacizumab, ranibizumab and aflibercept with PET/CT imaging on a non-human primate model Invest. Ophthalmol. Vis. Sci ;58(8):221. Figure Legend: Digital PET/CT Images captured with Philips Vereos scanner demonstrating intravitreal I-124 ranibizumab (color, left) and systemic biodistribution (B/W, right) 1 day after intravitreal injection of the right eye. Date of download: 10/14/2017 The Association for Research in Vision and Ophthalmology Copyright © All rights reserved.


Download ppt "From: Intravitreal pharmacokinetic properties and systemic biodistribution characteristics of I-124 labeled bevacizumab, ranibizumab and aflibercept with."

Similar presentations


Ads by Google